To assess toxicity and efficiency of dual-AAV9 infection of cardiomyocytes, we performed pilot experiments using two AAV9 viruses expressing fluorescent markers eGFP under the Tnnt2 promoter14 or mScarlet driven by the broadly expressed CMV promoter (Extended Data Fig. 1a). Here, TNNT2 is linked to infection.